Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Candel Therapeutics Inc.

    NASDAQ: CADL · Real-Time Price · USD
    5.96
    -0.13 (-2.13%)
    At close: Aug 18, 2025, 3:59 PM
    5.95
    -0.25%
    After-hours: Aug 18, 2025, 07:42 PM EDT

    Candel Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a 125K 125K
    Cost of Revenue
    		 990K 23.98M 987K 232K
    Gross Profit
    		 n/a -23.98M -862K -107K
    Operating Income
    		 -33.37M -38.39M -34.72M -25.73M
    Interest Income
    		 1.09M n/a 1.22M n/a
    Pretax Income
    		 -55.18M -37.94M -18.79M -36.12M
    Net Income
    		 -55.18M -37.94M -2.87M -36.18M
    Selling & General & Admin
    		 14.06M 14.41M 14.06M 10.67M
    Research & Development
    		 19.31M 24.51M 20.79M 15.18M
    Other Expenses
    		 n/a -24.51M -48K -1.08M
    Operating Expenses
    		 33.37M 14.41M 34.8M 24.77M
    Interest Expense
    		 2.09M 514K 1.71M 53K
    Selling & Marketing Expenses
    		 n/a 687K n/a n/a
    Cost & Expenses
    		 n/a 38.39M 34.8M 24.77M
    Income Tax Expense
    		 n/a n/a -15.93M 53K
    Shares Outstanding (Basic)
    		 31.68M 28.94M 28.82M 28.69M
    Shares Outstanding (Diluted)
    		 31.68M 28.94M 28.82M 28.69M
    EPS (Basic)
    		 -1.74 -1.31 -0.1 -1.26
    EPS (Diluted)
    		 -1.74 -1.31 -0.1 -1.26
    EBITDA
    		 -52.1M -37.43M -17.32M -25.49M
    EBIT
    		 -53.09M -38.39M -18.3M -24.65M
    Depreciation & Amortization
    		 990K 960K 987K 232K

    Add to Watchlist